Entrada Therapeutics (TRDA) Preferred Shares Issued (2021)
Entrada Therapeutics (TRDA) recorded quarterly Preferred Shares Issued of -$417000.0 in Q2 2021, down 100.36% quarter-over-quarter from $116.2 million in Q1 2021.
Entrada Therapeutics (TRDA) Preferred Shares Issued (2021) Analysis & Trends
Entrada Therapeutics' Preferred Shares Issued history runs 1 years deep, the most recent figure standing at -$417000.0 for Q2 2021.
- In Q2 2021, Preferred Shares Issued changed N/A year-over-year to -$417000.0; the TTM figure through Mar 2022 stood at -$417000.0 (changed N/A YoY), while the FY2023 annual figure was $19.4 million, changed N/A from the prior year.
- Preferred Shares Issued was -$417000.0 for Q2 2021 at Entrada Therapeutics, down from $116.2 million in the prior quarter.
- In the past five years, Preferred Shares Issued ranged from a high of $116.2 million in Q1 2021 to a low of -$417000.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Entrada Therapeutics | 295.36 Mn | 295.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -417,000.00 |
| Jun 30, 2021 | -417,000.00 |
| Mar 31, 2021 | 116.25 Mn |
| Mar 31, 2021 | 116.25 Mn |